Adenosine deaminase complexing protein in cancer studies

Area of Science:

• Biochemistry
• Oncology
• Immunology

Background:

• Adhesion-dependent cell adhesion molecule (ADCP) is a 200KD dimeric glycoprotein found in human tissues, primarily membrane-bound.
• Its physiological role remains largely unknown.
• Previous research suggested altered ADCP levels in various cancers, but findings were inconsistent.

Purpose of the Study:

• To review and analyze the current literature on ADCP in cancer studies.
• To evaluate the potential of ADCP as a diagnostic and prognostic marker in different human carcinomas.
• To explore ADCP's role in cell differentiation and its expression in specific T-cell subsets.

Main Methods:

• Literature review of ADCP in cancer studies.
• Immunohistochemical and quantitative biochemical analyses of ADCP in colorectal, prostatic, and renal carcinomas.
• Comparison of ADCP levels in primary versus virally transformed human fibroblasts.
• Analysis of ADCP expression in T-cell subsets.

Main Results:

• Soluble ADCP was reported decreased in lung, liver, kidney, and colon cancers, but these findings were not consistently confirmed in colorectal, prostatic, and renal carcinomas.
• ADCP levels were decreased in virally transformed fibroblasts but high in primary fibroblasts.
• ADCP presence in serum of renal adenocarcinoma patients correlated with better five-year survival.
• ADCP is selectively expressed by certain T-cell subsets.

Conclusions:

• ADCP's role as a consistent tumor marker across all investigated cancers is uncertain.
• ADCP may serve as a differentiation marker for colonic and renal carcinomas.
• Serum ADCP levels could be a prognostic marker for renal adenocarcinoma patients.
• ADCP's selective T-cell expression suggests potential in leukemia research.